Amarin reported $973.24M in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
DBV Technologies DBVT:US 284.98M 167.4M
Aerie Pharmaceuticals AERI:US $ 385.34M 10.21M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amarin AMRN:US $ 973.24M 0.47M
AstraZeneca AZN:LN 7932612.74M 297425.43M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Epizyme EPZM:US $ 264.16M 48.03M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
GlaxoSmithKline GSK:LN 8904500M 64400M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NOVN:VX SF 122910M 2308M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M